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Hematopoietic stem cells (HSCs) are rare populations in the 
bone marrow of adult mammals which produce millions of 
blood cells for daily circulation by balancing self-renewal 
and multi-lineage differentiation. In vertebrates, a subset of 
specialized mesodermal precursor cells commit to hemato-
poietic cells after gastrulation, which are separated into two 
major waves. The initial wave, termed primitive hemato-
poiesis, mainly exists in the mammalian yolk sac, which 
produces early erythroid cells to facilitate tissue oxygena-
tion during the rapid growth of embryos. The second wave, 
termed definitive hematopoiesis, gives rise to HSCs with 
long-term reconstitution capability that arise from hemo-
genic endothelium (HE) in the aorta-gonad mesonephros 
(AGM) region, as well as the placental labyrinth and vitel-
line and umbilical arteries, and subsequently colonize the 
fetal liver (FL), spleen, thymus, and eventually occupy the 
bone marrow (Orkin and Zon, 2008). In past decades, sev-
eral surface markers have been reported to identify the pre-
cursor of HSCs, so-called pre-HSCs, including CD41, 
CD45, CD31, c-Kit, vascular endothelial cadherin 
(VE-cadherin), etc. However, due to the rarity and du-
al-potential (both hematopoietic and endothelial) of 
pre-HSCs, their heterogeneity and unique surface markers 
remain elusive. In a study recently published on Nature, 
Zhou F et al for the first time captured the nascent 
pre-HSCs using a new combination of markers including 
CD201 (endothelial protein C receptor, EPCR) (Zhou et al., 
2016). Zhou F et al further developed the single-cell initiat-
ed serial transplantation, and validated that the 
CD31+CD45−CD41lowc-Kit+CD201high and CD31+CD45+c- 
Kit+CD201high subsets in the E11 AGM region could highly 
enrich T1 and T2 pre-HSCs at frequencies of 1:2.3 and 
1:2.1, respectively, indicating the high purity of pre-HSCs. 
Accumulated evidence has documented that heterogene-
ity is a feature of HSC proliferation, self-renewal, and dif-
ferentiation, which is finely-tuned by myriad intrinsic and 
extrinsic mechanisms, and is believed to play a role in dis-
ease evolution. Due to the rapidly evolving next-generation 
sequencing technology, several groups have developed sin-
gle-cell RNA sequencing (RNA-seq) techniques which 
could analyze the transcriptome at single-cell and sin-
gle-base resolutions (Tang et al., 2011). Together with the 
advances in flow cytometry allowing isolation of HSCs for 
single-cell transplantation assays of cellular fate choice, the 
molecular and functional heterogeneity as well as the cellu-
lar hierarchy have been demonstrated by several groups in 
both murine and human adult HSCs. These studies have 
identified key molecules that correlate with long-term 
self-renewal and have revealed single-cell molecular cir-
cuits that are linked to functionality of adult HSCs. Howev-
er, single-cell RNA-seq analyses in pre-HSCs in mouse 
mid-gestation embryos have not yet been fully explored. 
In their recent report, Zhou F et al made great efforts by 
performing multiple experiments, including single-cell 
co-culture/transplantation assays and single-cell RNA-seq, 
in five cell types related to HSC ontogeny, endothelial cells 
(ECs), T1 pre-HSCs, T2 CD41low HSCs, E12 and E14 FL 
HSCs. Principal component analysis (PCA) and unsuper-
vised hierarchical clustering analyses revealed that T2 
CD41low HSCs contained two subpopulations, with one be-
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ing similar to T1 pre-HSCs and the other exhibiting myeloid 
lineage signatures, indicating the presumed T2 CD41low 
HSCs were heterogeneous. Later, CD31+CD45+c- 
Kit+CD201high cells were proven to be functional T2 
pre-HSCs and were used to replace T2 CD41low HSCs. Fur-
ther, single-cell RNA-seq analyses suggested that the T1 
and T2 pre-HSCs were close to each other but distinct from 
ECs and FL HSCs, providing strong evidence to support the 
previous hypothesis that embryonic hematopoiesis develops 
from embryonic ECs to T1 and T2 pre-HSCs, and on to FL 
HSCs. Pre-HSCs have both hematopoietic and endothelial 
potential, but it is controversial whether HSCs originate 
from ECs either in major arteries or in veins (Ditadi et al., 
2015). The single-cell RNA-seq data showed that T1 
pre-HSCs expressed arterial markers but much lower levels 
of venous markers compared with ECs, suggesting that 
pre-HSCs might stem from arterial rather than venous ECs.  
More interestingly, Zhou F et al observed a 4.4-fold in-
crease in the average mRNA copy number, and a 6.9-fold 
increase in the absolute expression levels of 290 ribo-
some-associated genes in T1 pre-HSCs compared to ECs, 
respectively. These findings suggested that during ECs dif-
ferentiation into pre-HSCs, there is a tremendous increase in 
both transcriptional activity and ribosome-based transla-
tional machinery. Mechanistically, gene set enrichment 
analysis (GSEA) revealed that both oxidative phosphoryla-
tion and glycolysis pathways were hyperactivated in the T1 
pre-HSCs, implying that the entire mitochondrial metabo-
lism was specifically activated at this stage. mTOR pathway 
has been reported to enhance mitochondrial biogenesis, ac-
tivity and energy metabolism in HSCs and other systems 
(Qian et al., 2016). Indeed, mTOR pathway, especially the 
mTORC2 complex, was found highly enriched in T1 
pre-HSCs compared with ECs. When Rictor, core compo-
nent of mTORC2, was conditionally disrupted by endothe-
lial Tie2-cre, HSCs from mutant AGM exhibited strikingly 
lower repopulating capacity than controls, suggesting 
mTORC2 pathway was essential for HSC emergence from 
endothelial cells. Moreover, T1 pre-HSCs in S/G2/M phase 
had the highest reconstitution capacity, which was lower in 
G0 phase and almost nonexistent in G1 phase. These data 
are different from adult HSCs which are in G0 phase, and 
from E14 FL HSCs which are in G1 phase, indicating the 
heterogeneity in cell cycle status of T1 pre-HSCs. The  
mechanisms underlying correlation between pre-HSC cell 
cycle status and functionality merit future investigation. 
Although hematopoietic stem cell transplantation 
(HSCT) has been widely used for treatment of congenital 
and acquired hematopoietic malignancies for decades, do-
nor availability and allogenicity remain unresolved issues. 
Compared to the strategies of using transcriptional factors to 
reprogram somatic cells into HSCs, or to differentiate 
ES/iPS into HSCs, it might be safer to mimic the HSC on-
togeny in vivo and induce ES/iPS cells into HSCs ex vivo by 
use of cytokines and growth factors. However, such at-
tempts have been largely unsuccessful due to our limited 
understanding of embryonic hematopoiesis. In this study, 
Zhou F et al comprehensively analyzed the transcriptomes 
of ECs, pre-HSCs, and FL HSCs at the single cell level, and 
revealed the underlying mechanisms for HSC emergence, 
providing extremely important information about signaling 
pathways and molecules by which the arterial endothelial 
cells give rise to the first definitive pre-HSCs. Moreover, 
since definitive HSCs arise not only from the AGM region, 
but also from other sites including head, placental labyrinth, 
and vitelline and umbilical arteries, it is worthwhile to per-
form single-cell RNA-seq in these regions and to compare 
the differences of molecular regulation network among 
these distinct sites. 
Compliance and ethics  The author(s) declare that they have no conflict 
of interest. 
Ditadi, A., Sturgeon, C.M., Tober, J., Awong, G., Kennedy, M.,Yzaguirre, 
A.D., Azzola, L., Ng, E.S., Stanley, E.G., French, D.L., Cheng, X., 
Gadue, P., Speck, N.A., Elefanty, A.G., and Keller, G. (2015). Human 
definitive haemogenic endothelium and arterial vascular endothelium 
represent distinct lineages. Nat Cell Biol 17, 580–591. 
Qian, P., He, X.C., Paulson, A., Li, Z.R., Tao, F., Perry, J.M., Guo, F.L., 
Zhao, M., Zhi, L., Venkatraman, A., Haug, J.S., Parmely, T., Li, H., 
Dobrowsky, R.T., Ding, W.X., Kono, T., Ferguson-Smith, A.C., and Li, 
L.H. (2016). The dlk1-gtl2 locus preserves lt-hsc function by inhibiting 
the pi3k-mtor pathway to restrict mitochondrial metabolism. Cell Stem 
Cell 18, 214–228. 
Orkin, S.H., and Zon, L.I. (2008). Hematopoiesis: An evolving paradigm 
for stem cell biology. Cell 132, 631–644. 
Tang, F., Lao, K., and Surani, M.A. Development and applications of 
single-cell transcriptome analysis. Nat Methods 8, S6–S11. 
Zhou, F., Li, X., Wang, W., Zhu, P., Zhou, J., He, W.Y., Ding, M., Xiong, 
F.Y., Zheng, X.N., Li, Z., Ni, Y.L., Mu, X.H., Wen, L., Cheng, T., Lan, 
Y., Yuan, W.P., Tang, F,C., and Liu, B. (2016). Tracing haematopoietic 
stem cell formation at single-cell resolution. Nature 533, 487–492. 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
